EFFICACY AND SAFETY OF BARICITINIB AND TOFACITINIB IN RHEUMATOID ARTHRITIS: DATA FROM REAL-WORLD

被引:0
|
作者
Gonzalez Mazario, R. [1 ]
Fragio-Gil, J. J. [1 ]
Grau Garcia, E. [1 ]
De la Rubia Navarro, M. [1 ]
Pavez Perales, C. [1 ]
Leal Rodriguez, S. [1 ]
Ivorra Cortes, J. [1 ]
Negueroles Albuixech, R. [1 ]
Gonzalez Puig, L. [1 ]
Oller Rodriguez, J. E. [1 ]
Alcaniz Escandell, C. [1 ]
Vicens Bernabeu, E. [1 ]
Chalmeta Verdejo, I. [1 ]
Martinez Cordellat, I. [1 ]
Ortiz Sanjuan, F. M. [1 ]
Najera Herranz, C. [1 ]
Canovas Olmos, I. [1 ]
Canada Martinez, A. J. [2 ]
Roman Ivorra, J. A. [1 ]
机构
[1] Hosp Univ & Politecn La Fe, Rheumatol, Valencia, Spain
[2] Inst Invest Sanitaria La Fe Valencia, Biostat, Valencia, Spain
关键词
D O I
10.1136/annrheumdis-2020-eular.6321
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI0124
引用
收藏
页码:639 / 640
页数:2
相关论文
共 50 条
  • [1] Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis
    Naoki Iwamoto
    Shuntaro Sato
    Shota Kurushima
    Toru Michitsuji
    Shinya Nishihata
    Momoko Okamoto
    Yoshika Tsuji
    Yushiro Endo
    Toshimasa Shimizu
    Remi Sumiyoshi
    Takahisa Suzuki
    Akitomo Okada
    Tomohiro Koga
    Shin-ya Kawashiri
    Keita Fujikawa
    Takashi Igawa
    Toshiyuki Aramaki
    Kunihiro Ichinose
    Mami Tamai
    Hideki Nakamura
    Akinari Mizokami
    Tomoki Origuchi
    Yukitaka Ueki
    Katsumi Eguchi
    Atsushi Kawakami
    [J]. Arthritis Research & Therapy, 23
  • [2] Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis
    Iwamoto, Naoki
    Sato, Shuntaro
    Kurushima, Shota
    Michitsuji, Toru
    Nishihata, Shinya
    Okamoto, Momoko
    Tsuji, Yoshika
    Endo, Yushiro
    Shimizu, Toshimasa
    Sumiyoshi, Remi
    Suzuki, Takahisa
    Okada, Akitomo
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Fujikawa, Keita
    Igawa, Takashi
    Aramaki, Toshiyuki
    Ichinose, Kunihiro
    Tamai, Mami
    Nakamura, Hideki
    Mizokami, Akinari
    Origuchi, Tomoki
    Ueki, Yukitaka
    Eguchi, Katsumi
    Kawakami, Atsushi
    [J]. ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [3] EFFECTIVENESS OF A SWITCH FROM TOFACITINIB TO BARICITINIB IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE ANALYSIS OF REAL-WORLD DATA IN SWITZERLAND
    Kellerhals, S.
    Amsler, J.
    Schulze-Koops, H.
    Hugle, T.
    Nissen, M. J.
    Paul, H.
    Kyburz, D.
    Muller, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1161 - 1161
  • [4] DIRECT COMPARISON OF EFFECTIVENESS AND SAFETY OF TOFACITINIB AND BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL-WORLD SETTINGS
    Iwamoto, N.
    Suzuki, T.
    Okada, A.
    Fujikawa, K.
    Aramaki, T.
    Mizokami, A.
    Ueki, Y.
    Kawakami, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 581 - 581
  • [5] Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis
    Bertoldi, Ilaria
    Caporali, Roberto
    [J]. OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2021, 13 : 221 - 237
  • [6] REAL-WORLD USE OF TOFACITINIB IN RHEUMATOID ARTHRITIS: DATA FROM LATIN AMERICA
    Schneeberger, E. E.
    Salas, A.
    Medina, L. F.
    Zacariaz, J. B.
    Mantilla, R. D.
    Sarmiento-Monroy, J. C.
    Elizondo, L. J.
    Garro, B.
    Madariaga, H.
    Gorriz, L.
    Giorgi, R. D. N.
    Butte, K.
    Ventura, R.
    Tate, P.
    Ranza, R.
    Coronado, P.
    Forero, E.
    Rodrigues, W.
    Roa, Y.
    Larroude, M.
    Vasquez, R.
    Belini, A.
    Amador, L.
    Solano, G.
    Sanguino, F.
    Aracena, G.
    Ponce de Leon, D.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S73 - S74
  • [7] Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis
    Hirose, Wataru
    Harigai, Masayoshi
    Amano, Koichi
    Hidaka, Toshihiko
    Itoh, Kenji
    Aoki, Kazutoshi
    Nakashima, Masahiro
    Nagasawa, Hayato
    Komano, Yukiko
    Nanki, Toshihiro
    [J]. RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (03)
  • [8] Real-world observational study of patients with rheumatoid arthritis treated with baricitinib or tofacitinib in a tertiary hospital
    Guillen Benitez, Elena
    Sabate Gallego, Monica
    Ballarin Alins, Elena
    Espartal Lopez, Esther
    Lopez Lasanta, Maria
    Bosch Ferrer, Montserrat
    Artilagas Boixareu, Nuria
    Alerany Pardo, Carmen
    Danes Carreras, Immaculada
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 16 - 17
  • [9] Real-world experience with tofacitinib for the treatment of rheumatoid arthritis
    Caporali, Roberto
    Zavaglia, Daniela
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : 485 - 495
  • [10] BARICITINIB AS MONOTHERAPY FOR TREATMENT OF RHEUMATOID ARTHRITIS: SUMMARY OF DATA FROM FIVE REAL-WORLD DATA SOURCES
    Edwards, C. J.
    Finckh, A.
    Takeuchi, T.
    Kleyer, A.
    Haladyj, E.
    Laedermann, C.
    Gerwien, J.
    Treuer, T.
    Zaremba-Pechmann, L.
    Smolen, J. S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1419 - 1419